BabaS.: AT 2266: clinical activity and antibacterial properties. Otologia, 26; 863 (1980).
2.
DobsonR. A.: In vitro antimicrobial activity of rosoxacin against neisseria gonorrhoeae, Chlamidya trachomatis and Ureaplasma urealyticum. Antimicrob. Agents Chemother., 18; 738 (1980).
3.
HubrechtsJ. M.: Oral treatment of systemic Pseudomonas aeruginosa infection with enoxacin. Lancet, 1; 860 (1984).
4.
KaminskyD., MeltzerR. I.: Quinolone antibacterial agents. Oxolinic acid and related compounds. J. Med. Chemoth. (United States), 11; 160 (1968).
5.
KhanM. Y.: Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents urinary bacterial isolates. Antimicrob. Agents Chemother., 21; 848 (1982).
6.
KogaH.: Structure-activity relationships of antibacterial 6,7- and 7,8- disubstituted 1-alkyl-1,4-dihydro-4oxoquinoline-3-carboxylic acids. J. Med. Chemother., 23; 1358 (1980).
7.
ItoA.: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob. Agents Chemothre., 17; 103 (1980).
8.
NakamuraS.: In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob. Agents Chemother., 23; 641 (1983).
9.
NakamuraS.: AT 2266, a new pyridonecarboxylic acid: antibacterial activity and properties. Antimicrob. Agents Chemother., 23; 641 (1983).
10.
SambeB.: Enoxacin: antimicrobial activity and clinical studies in ENT indications. Otologia, 23; 807 (1977).
11.
ShimizuM.: Pipemidic acid: absorption, distribution and excretion. Antimicrob. Agents Chemother., 7; 441 (1975).
12.
ShimizuM.: Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties. Antimicrob. Agents Chemother., 8; 132 (1975).
13.
ShimizuM.: Enoxacin: pharmacokinetic properties and in vitro activity. Curr. Chemother. Inf. Disease, 451 (1980).
